Those that follow my articles know that I tend to focus mainly on undervalued microcap or smallcap biotech companies. A lot of my …
Investors cheer as CLBS expands.
While shares of stem cell company Athersys, Inc. (NASDAQ:ATHX) are trading up over 20% following new partnership agreement in Japan, shares of biotech company Caladrius Biosciences …
WBB Securities analyst Stephen Brozak came out today with a favorable report on Caladrius Biosciences Inc (NASDAQ:CLBS), after the company announced Tuesday that it has signed …
Caladrius Biosciences Inc (NASDAQ:CLBS), a cell therapy company combining an industry-leading external development and manufacturing provider (PCT) with a development pipeline in immunotherapy, announced …
Recently, various executives have taken part in insider trading activity for the stocks of Cytori Therapeutics Inc (NASDAQ:CYTX), Caladrius Biosciences Inc (NASDAQ:CLBS), FireEye Inc (NASDAQ:FEYE), and Gran Tierra Energy …
